Patentability of Methods of Human Enhancement

Journal of Intellectual Property Law & Practice (2015) 10 (1): 19-28.

Posted: 1 Dec 2015

See all articles by Ana Nordberg

Ana Nordberg

Faculty of Law, Lund University, Sweden

Date Written: November 30, 2015

Abstract

This article explores how to apply patentability rules to human enhancement, particularly focusing on Article 53(c) of the European Patent Convention (EPC).

The global size and value of the cosmetic and wellness market and industry allow for the prediction of considerable market potential for human enhancement. Patents will be instrumental for companies to protect investment in innovation and tap into this potentially valuable market.

The European patent system contains, in Article 53(c) EPC, an exception from patentability for methods for treatment and diagnostic methods. Such rule was created, and subsequently developed through European Patent Office (EPO) case law, by reference to the dichotomy between therapeutic and cosmetic methods. Subsuming enhancement methods under this patentability rule may be challenging. Ultimately, patentability of human enhancement will depend on the concept of health, its future evolution and the corresponding public policy choices. This article seeks to provide prospective patentees with guidance and awareness concerning the patentability of methods for human enhancement.

Keywords: Human Enhancement, Patent, EPC, Medical methods, Patentability Exceptions

Suggested Citation

Nordberg, Ana, Patentability of Methods of Human Enhancement (November 30, 2015). Journal of Intellectual Property Law & Practice (2015) 10 (1): 19-28.. Available at SSRN: https://ssrn.com/abstract=2697132

Ana Nordberg (Contact Author)

Faculty of Law, Lund University, Sweden ( email )

Lilla Gråbrödersgatan 4
Lund, 222 22
Sweden
+46462221054 (Phone)

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
196
PlumX Metrics